We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index. (NOMAC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01437917
First Posted: September 21, 2011
Last Update Posted: May 16, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Institut National de la Recherche Agronomique
Information provided by (Responsible Party):
Rennes University Hospital
  Purpose
The consumption of cereals-based foods with low glycemic indexes, high micronutrients and fibers contents are highly recommended. The target of this work is to provide new solutions for cereal based foods: the knowledge and understanding on the in vivo fate will be used to define structural features to gain in foods.

Condition Intervention
Healthy Other: 20% amylose bread Dietary Supplement: 10% amylose bread Dietary Supplement: Carbohydrates

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Official Title: NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.

Further study details as provided by Rennes University Hospital:

Primary Outcome Measures:
  • Glycemic index for each bread [ Time Frame: 2 hours ]
    To compare the glycemic index of breads made with different amylose content. (S1 to S6) A total of 6 visits. In each visit, blood samples will be taken for measurement of glycemia and insulinemia over 2 hours after ingestion of 50 of carbohydrates ingested with 400 ml of water.


Secondary Outcome Measures:
  • AUC for insulinemia for the 2 hours following the ingestion of each bread. [ Time Frame: 2 hours ]
    To compare the AUC for insulinemia for the 2 hours following the ingestion of each bread.


Enrollment: 10
Study Start Date: September 2011
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Bread with 20% amylose content
Bread with 20% amylose content
Other: 20% amylose bread
20% amylose bread
Experimental: Bread with 10% amylose content
Bread with 10% amylose content
Dietary Supplement: 10% amylose bread
10% amylose bread
Experimental: carbohydrates
50g of carbohydrates ingested with 400 ml of water
Dietary Supplement: Carbohydrates
50g of carbohydrates ingested with 400 ml of water

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy individual,
  • Age between 19-65 years
  • With normal food habits with at least 2 main meals per day
  • Non smoking
  • Having filled the consent form

Exclusion Criteria:

  • BMI > 25 kg/m2,
  • Diabetes or any illness susceptible to alter
  • Coeliac disease
  • Past history of intestinal diseases.
  • Treatment susceptible of modifying glycemia.
  • Allergy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01437917


Locations
France
Rennes University Hospital
Rennes, Bretagne, France, 35033
Sponsors and Collaborators
Rennes University Hospital
Institut National de la Recherche Agronomique
Investigators
Principal Investigator: Fabrice BONNET, MD Rennes University Hospital
  More Information

Responsible Party: Rennes University Hospital
ClinicalTrials.gov Identifier: NCT01437917     History of Changes
Other Study ID Numbers: LOC/11-05 - NOMAC
2011-A00517-34 ( Other Identifier: ID RCB )
11/19-808 ( Other Identifier: CPP Ouest V )
B110607-50 ( Other Identifier: AFSSAPS )
First Submitted: September 20, 2011
First Posted: September 21, 2011
Last Update Posted: May 16, 2012
Last Verified: May 2012

Keywords provided by Rennes University Hospital:
glycemic index